Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site. 1988

D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
Department of Biochemistry, University of New Mexico School of Medicine, Albuquerque 87131.

Aldose reductase from human placenta was purified to homogeneity by a rapid (2 day) and efficient purification scheme involving Red Sepharose affinity chromatography, chromatofocusing and high performance liquid chromatography on a size-exclusion column. Addition of NADP+ at all steps in the purification of aldose reductase and during storage of the enzyme at -20 degrees stabilized both the enzyme active site and the major site for binding of aldose reductase inhibitors such as sorbinil and tolrestat. Aldose reductase is a monomer with a molecular mass of 38 kD by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, apparent pI 5.9. Placenta aldose reductase exhibited no cross-reactivity with aldehyde reductase from human liver in an ELISA assay. Aldose reductase showed broad specificity for aldehydes, was specific for NADPH, and was activated by sulfate.

UI MeSH Term Description Entries
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000426 Alcohol Dehydrogenase A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen. Alcohol Dehydrogenase (NAD+),Alcohol Dehydrogenase I,Alcohol Dehydrogenase II,Alcohol-NAD+ Oxidoreductase,Yeast Alcohol Dehydrogenase,Alcohol Dehydrogenase, Yeast,Alcohol NAD+ Oxidoreductase,Dehydrogenase, Alcohol,Dehydrogenase, Yeast Alcohol,Oxidoreductase, Alcohol-NAD+
D000449 Aldehyde Reductase An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Aldose Reductase,Aldose Reductase Ia,Aldose Reductase Ib,Erythrose Reductase,Xylose Reductase,Reductase Ia, Aldose,Reductase Ib, Aldose,Reductase, Aldehyde,Reductase, Aldose,Reductase, Erythrose,Reductase, Xylose
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013401 Sugar Alcohol Dehydrogenases Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99. Sugar Alcohol Oxidoreductases,Alcohol Dehydrogenases, Sugar,Alcohol Oxidoreductases, Sugar,Dehydrogenases, Sugar Alcohol,Oxidoreductases, Sugar Alcohol

Related Publications

D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
January 1978, Archives of biochemistry and biophysics,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
April 1986, Metabolism: clinical and experimental,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
September 1998, European journal of biochemistry,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
January 1991, Protein expression and purification,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
November 1983, Molecular pharmacology,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
November 1991, Biochemistry international,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
October 1998, Bioorganic & medicinal chemistry,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
May 1985, Archives of biochemistry and biophysics,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
November 1983, Experimental eye research,
D L Vander Jagt, and L A Stangebye, and L A Hunsaker, and R P Eaton, and W L Sibbitt
June 1981, Analytical biochemistry,
Copied contents to your clipboard!